Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.

Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.

Item
http://www.wikidata.org/entity/Q41457814
Response of complicated methicillin-resistant Staphylococcus aureus endocarditis to the addition of trovafloxacin.Gatifloxacin: a new fluoroquinolone.Advances in DNA gyrase inhibitors.Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban populationMoxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.Serum and prostatic tissue concentrations of moxifloxacin in patients undergoing transurethral resection of the prostate.Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK ModelInter-individual variability in the pre-clinical drug cardiotoxic safety assessment--analysis of the age-cardiomyocytes electric capacitance dependence.10 years' experience with the pneumococcal quinolone moxifloxacin.Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.Activities of moxifloxacin against, and emergence of resistance in, Streptococcus pneumoniae and Pseudomonas aeruginosa in an in vitro pharmacokinetic model.Acute cholecystitis - early laparoskopic surgery versus antibiotic therapy and delayed elective cholecystectomy: ACDC-studyIn vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental modelDual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureusEffect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.
P2860

Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.

Item
http://www.wikidata.org/entity/Q41457814
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.
@en
type
label
Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.
@en
prefLabel
Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Moxifloxacin (Bay 12-8039): a new methoxy quinolone antibacterial.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921